Corpus Callosotomy for Treatment of Pediatric Epilepsy in the Modern Era

2007 ◽  
Vol 43 (3) ◽  
pp. 202-208 ◽  
Author(s):  
Scott Y. Rahimi ◽  
Yong D. Park ◽  
Mark R. Witcher ◽  
Ki H. Lee ◽  
Manuel Marrufo ◽  
...  
Author(s):  
Christopher Markosian ◽  
Saarang Patel ◽  
Sviatoslav Kosach ◽  
Robert R. Goodman ◽  
Luke D. Tomycz

2011 ◽  
Vol 42 (S 01) ◽  
Author(s):  
T Getzinger ◽  
T Pieper ◽  
S Keßler-Uberti ◽  
B Pascher ◽  
H Eitel ◽  
...  

2020 ◽  
Vol 09 (04) ◽  
pp. 177-185
Author(s):  
Natalie Guido-Estrada ◽  
Shifteh Sattar

AbstractThere is scarce evidence in review of the available literature to support a clear and superior model for the transition of care for epilepsy patients from pediatric to adult centers. Anecdotally, there is a common perception that families are reluctant to make this change and that the successful transition of care for epilepsy can be a challenge for patients, families, and physicians. As part of the effort to prepare the patient and family for the adult model of care, several treatment issues should be addressed. In this article, we discuss the specific challenges for physicians in transition of care for epilepsy patients from a pharmacological standpoint, which include differences in metabolism and pharmacodynamics that can impact tolerability or efficacy of antiepileptic medications, lifestyle changes affecting medication compliance and seizure control, acquired adult health conditions necessitating new medications that may result in adverse drug interactions, and adult neurologists' potential lack of familiarity with certain medications typically used in the pediatric epilepsy population. We offer this as a guide to avoid one of the many possible pitfalls when epilepsy patients transition to adult care.


2017 ◽  
Vol 23 (2) ◽  
Author(s):  
SANJAY A. KHAIRNAR

In modern era about 80% of the world population depends on herbal alternative system of medicine. Seventy thousand plants are used in medicine and about 2000 plants are used in Indian Ayurveda. The activities of the curative plants are evaluated by their chemical components. Few of them are important as a medicine but also posses poisonous or toxic properties. The toxicity is produced in them due to the synthesis of toxic chemical compounds may be in primary or secondary phase of their life. Most of the users of such medicinal plants in crude form are tribal and peoples living in the forests and their domestic stock . Most of the time these peoples may not aware about the toxicity of such plants used by them and probably get affected sometimes even leads to death. In the study area during the field survey of poisonous plants, information are gathered from the traditional practicing persons, cow boy and from shepherds. About 20 plant species belonging to 17 families are reported as a medicinal as well as toxic. From the available literature, nature of toxic compound and symptoms of their intake on human being are recorded. In the study area the plants like, Abrus precatorious commonly known as a Gunj or Gunjpala, Jatropha curcas , (Biodiesel plant), Croton tiglium (Jamalgota), Citrullus colocynthis (Kadu Indrawan, Girardinia diversifolia (Agya), Mucuna purriens (Khajkuairi), Euphorbia tirucali (Sher), E. ligularia (Sabarkand), Datura metel ( Kala Dhotara), Datura inoxia (Pandhara Dhotara) and Asparagus racemo-sus (Shatavari) etc . are some of the toxic plants used as a medicine and harmful also.


Sign in / Sign up

Export Citation Format

Share Document